Stay updated with breaking news from David Lebwohl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price traded up 11.3% during trading on Tuesday . The company traded as high as $31.13 and last traded at $30.79. 2,174,127 shares changed hands during trading, an increase of 39% from the average session volume of 1,563,047 shares. The stock had previously closed at $27.66. […]
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) posted its earnings results on Thursday. The company reported ($1.46) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.01, Briefing.com reports. The business had revenue of ($1.92) million during the quarter, compared to analyst estimates of $15.10 million. Intellia Therapeutics had a negative return on […]
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) issued its earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative return on equity of 43.31% and a negative net margin of 893.34%. The business had revenue of […]
The Goldman Sachs Group downgraded shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) from a buy rating to a neutral rating in a report issued on Friday morning, Marketbeat.com reports. The Goldman Sachs Group currently has $32.00 price objective on the stock, down from their previous price objective of $136.00. NTLA has been the subject […]
DekaBank Deutsche Girozentrale lifted its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 53,129 shares of the company’s stock after purchasing an additional 3,129 shares during the […]